Exploratory Clinical Neuroscience Research on Substance Use Disorders
Grant Opportunity Analysis
The National Institutes of Health is offering a federal grant to support exploratory clinical neuroscience research on substance use disorders through a phased R61/R33 innovation award. The project focuses on clinical research that is exploratory and developmental in nature, with work aimed at understanding the neurobiological mechanisms underlying substance use disorders and fundamental brain function relevant to substance use. The award is intended for projects that require budgets above the R21 mechanism, carries no matching requirement, and is expected to make about six awards. The opportunity is posted with an estimated application close date of July 10, 2026, and questions may be directed to NIDA_DNB_BCNB_r61@nih.gov.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Documents
No documents available for this grant.